The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

LVIII.bd

Path: Pulmonary veno-occlusive disease (PVOD)

Publications

Maeda K, Saiki Y, Yamaki S

In situ thrombosis of small pulmonary arteries in pulmonary hypertension developing after chemotherapy for malignancy.

Pulmonary medicine 2015;2015;230846 — 2015 — 230846

Ranchoux B, Günther S, Quarck R, Chaumais MC, Dorfmüller P, Antigny F, Dumas SJ, Raymond N, Lau E, Savale L, Jaïs X, Sitbon O, Simonneau G, Stenmark K, Cohen-Kaminsky S, Humbert M, Montani D, Perros F

Chemotherapy-induced pulmonary hypertension: role of alkylating agents.

The American journal of pathology 2015 Feb;185;356-71 — 2015 Feb — 356-71

Miyata D, Fukushima T, Matsunaga M, Saito N, Kato Y, Takahashi-Igari M, Horigome H, Sumazaki R, Yamaki S, Matsui A

Fatal pulmonary veno-occlusive disease after chemotherapy for Burkitt's lymphoma.

Pediatrics international : official journal of the Japan Pediatric Society 2011 Jun;53;403-5 — 2011 Jun — 403-5

Knight BK, Rose AG

Pulmonary veno-occlusive disease after chemotherapy.

Thorax 1985 Nov;40;874-5 — 1985 Nov — 874-5

Bentur L, Cullinane C, Wilson P, Greenberg M, O'Brodovich H, Silver MM

Fatal pulmonary arterial occlusive vascular disease following chemotherapy in a 9-month-old infant.

Human pathology 1991 Dec;22;1295-8 — 1991 Dec — 1295-8